The Magazine for Sleep Professionals
Saturday, October 10, 2026
Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep, and less daytime sleepiness when sleeping with a weighted chain blanket. Results of the randomized, controlled study show that participants using […]
SleepScore Labs, the Sleep Science Company behind the world’s most comprehensive suite of data-backed sleep solutions, has announced its partnership with Ebb Therapeutics® and has added the wearable CoolDrift™ sleep device to its assortment of scientifically-validated products. The Ebb CoolDrift technology tackles the pervasive issue of sleeplessness, offering a solution to help […]
June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of Sleep Medicine (AASM), Society of Behavioral Sleep Medicine (SBSM) and American Alliance for Healthy Sleep (AAHS) are working to raise awareness of the disease with Insomnia Awareness Night […]
Merck has announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for an update to the prescribing information for BELSOMRA® (suvorexant) C-IV to include findings on its use for the treatment of insomnia in patients with mild-to-moderate Alzheimer’s disease. BELSOMRA is indicated for the treatment […]
Approval Based on Robust Clinical Development Program That Included Two Pivotal Trials of Nearly 2,000 Patients Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced the U.S. Food and Drug Administration (FDA) approved DAYVIGOTM (lemborexant) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized […]
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from its company-sponsored survey, titled “How America Sleeps and Wakes,” was presented at the 2019 World Sleep Congress in Vancouver, Canada. The survey explored the impact of insomnia or sleeping difficulties on individual performance, interpersonal relationships […]
By Jacqueline Kloss, PhD In casual conversation, I find myself describing what I do professionally, and it goes something like this: I teach behavioral strategies and research ways to help individuals, especially women, overcome their sleep problems. All too often, I am met with the response of “That is what […]
Preliminary findings from two analyses of an ongoing study suggest that cognitive behavioral therapy for insomnia delivered by telemedicine is as effective as face-to-face delivery. Results of a randomized controlled non-inferiority trial show that both delivery methods were equally effective at improving sleep outcomes measured by sleep diaries, reducing self-reported […]
The Food and Drug Administration (FDA) is advising that rare but serious injuries have happened with certain common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while not fully awake. These complex sleep behaviors have also resulted in deaths. These behaviors appear […]
Innovative Neurological Devices received FDA market clearance for the Cervella™ Cranial Electrotherapy Stimulator for the treatment of anxiety, depression, and insomnia. Cervella works by delivering micro-pulses of electrical current across the patient’s brain. According to clinical studies, this electrical stimulation results in a reduction in anxiety levels, insomnia, and patient’s depressive mood. […]
